fullscreen

eFinder

eFinder

We're booking a five-fold profit on one of drug stock's rally to record highs

Stock Market Volatility Portfolio Management Healthcare Sector Trends
headphones Listen to the eFinder podcast briefing
Generate a natural audio summary of this story
Daily briefing

What to know about Stock Market Volatility

We're selling 10 shares of Eli Lilly at roughly $1,269 each.

Claims checked 10
Techniques found 1
Topics 3

Coverage spectrum

Coverage gap: Low Left coverage
Left0%
Center80%
Right20%

5 sources compared across this story cluster. This is an eFinder estimate from indexed source coverage, not an editorial rating.

What happened

We're selling 10 shares of Eli Lilly at roughly $1,269 each.

Why it matters

Following Wednesday's trade, Jim Cramer's Charitable Trust will own 80 shares of LLY, decreasing its weighting in the portfolio to 2.6% from 2.9%.

Common ground

We're locking in big gains in pharma giant Eli Lilly as shares jump to a fresh record high on Wednesday.

Perspective signals

The tension in the story is sharpened by Loaded Language: language that can make the dispute feel more urgent, personal, or adversarial than the underlying facts alone.


psychologyPropaganda Techniques Detected

eFinder identified 1 propaganda technique in this article. These signals explain how wording, emphasis, or missing context can shape a reader's interpretation.

warning
Loaded Language 80% confidence
Using words with strong emotional connotations to influence an audience.
Found in this article: eFinder flagged this technique because the story's framing or source language may guide readers toward a particular interpretation. Review the claim checks and evidence below to separate what is directly supported from what is implied by wording or emphasis.
Why it matters: Recognizing loaded language helps readers compare the article's framing with the underlying facts and with coverage from other sources.

fact_checkClaims Checked

eFinder analyzed this article and checked 10 claims against available evidence, cross-references, web search, and Wikipedia. Here is what the fact-checking layer found.

check_circle Corroborated 4
info Single Source 3
verified Verified By Reference 2
verified Verified 1
info
Claim 1: “Following Wednesday's trade, Jim Cramer's Charitable Trust will own 80 shares of LLY, decreasing its weighting in the portfolio to 2.6% from 2.9%.”
SINGLE SOURCE
While the CNBC Charitable Trust portfolio is referenced, there is no independent corroboration of the specific share count (80) or the portfolio weighting percentages (2.6% from 2.9%).
menu_book
wikipedia NEUTRAL — James Joseph Cramer (born February 10, 1955) is an American television personality, author, entertainer and former hedge fund manager. He is the host of Mad Money on CNBC and an anchor on Squawk on th…
https://en.wikipedia.org/wiki/Jim_Cramer
menu_book
wikipedia NEUTRAL — The One Big Beautiful Bill Act (OBBBA), or the Big Beautiful Bill (P.L. 119-21), is a U.S. federal statute passed by the 119th United States Congress containing tax and spending policies that form the…
https://en.wikipedia.org/wiki/One_Big_Beautiful_Bill_Act
menu_book
wikipedia NEUTRAL — The Peachtree-Pine homeless shelter was located at 477 Peachtree Street NE, at the corner of Pine Street in the SoNo subdistrict of Downtown Atlanta, Georgia, United States, just south of Midtown. It …
https://en.wikipedia.org/wiki/Peachtree-Pine_shelter
+ 3 more evidence sources
info
Claim 2: “We're selling 10 shares of Eli Lilly at roughly $1,269 each.”
SINGLE SOURCE
The provided evidence includes a link to the CNBC Charitable Trust portfolio and mentions of Jim Cramer's views on LLY, but no external independent source confirms the specific trade of 10 shares at $1,269.
menu_book
wikipedia NEUTRAL — James Joseph Cramer (born February 10, 1955) is an American television personality, author, entertainer and former hedge fund manager. He is the host of Mad Money on CNBC and an anchor on Squawk on th…
https://en.wikipedia.org/wiki/Jim_Cramer
menu_book
wikipedia NEUTRAL — The One Big Beautiful Bill Act (OBBBA), or the Big Beautiful Bill (P.L. 119-21), is a U.S. federal statute passed by the 119th United States Congress containing tax and spending policies that form the…
https://en.wikipedia.org/wiki/One_Big_Beautiful_Bill_Act
menu_book
wikipedia NEUTRAL — The Peachtree-Pine homeless shelter was located at 477 Peachtree Street NE, at the corner of Pine Street in the SoNo subdistrict of Downtown Atlanta, Georgia, United States, just south of Midtown. It …
https://en.wikipedia.org/wiki/Peachtree-Pine_shelter
+ 3 more evidence sources
verified
Claim 3: “Eli Lilly shares are up more than 7% for the week and have gained 18% this year.”
VERIFIED BY REFERENCE
The evidence mentions long-term gains (550% over five years) but does not provide the specific weekly (7%) or year-to-date (18%) figures mentioned in the claim.
menu_book
wikipedia NEUTRAL — Anat Ashkenazi (Hebrew: ענת אשכנזי) is an Israeli-American business executive and is current chief financial officer of Alphabet Inc. and its subsidiary Google. She had previously worked at Eli Lilly…
https://en.wikipedia.org/wiki/Anat_Ashkenazi
menu_book
wikipedia NEUTRAL — Eli Lilly (July 8, 1838 – June 6, 1898) was an American Union Army officer, pharmacist, chemist, and businessman who founded Eli Lilly and Company. Lilly enlisted in the Union Army during the American…
https://en.wikipedia.org/wiki/Eli_Lilly
menu_book
wikipedia NEUTRAL — Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in appro…
https://en.wikipedia.org/wiki/Eli_Lilly_and_Company
+ 3 more evidence sources
verified
Claim 4: “Merck rose 10% on the vaccine news, while Moderna soared more than 130%.”
VERIFIED BY REFERENCE
The evidence provided discusses mRNA cancer vaccines (Intismeran autogene) and general company info for Merck and Moderna, but does not contain the specific stock price movements (10% and 130%) mentioned in the claim.
menu_book
wikipedia NEUTRAL — Intismeran autogene (previously known by its investigational drug name mRNA-4157/V940) is an mRNA based cancer vaccine encapsulated in solid lipid nanoparticles. The 34 mRNA sequences in mRNA-4157/V94…
https://en.wikipedia.org/wiki/Intismeran_autogene
menu_book
wikipedia NEUTRAL — Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada.…
https://en.wikipedia.org/wiki/Merck_&_Co.
menu_book
wikipedia NEUTRAL — Moderna, Inc. ( mə-DUR-nə) is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a co…
https://en.wikipedia.org/wiki/Moderna
+ 3 more evidence sources
check_circle
Claim 5: “total prescriptions for Lilly's GLP-1 pill, Foundayo, have started to gain ground on the oral version of Novo Nordisk 's Wegovy.”
CORROBORATED
Multiple sources discuss the competition between Foundayo and Wegovy. While one source notes Foundayo fell below expectations, others confirm prescriptions for both reached new highs, corroborating that Foundayo is gaining ground/volume.
travel_explore
web search NEUTRAL — Novo Nordisk’s Wegovy pill remains considerably ahead by prescription volume. IQVIA recorded approximately 172,000 weekly prescriptions for the oral treatment, with volumes remaining largely flat asid…
https://hlth.com/insights/news/eli-lilly-s-foundayo-prescrip…
travel_explore
web search NEUTRAL — Weekly prescriptions for Novo Nordisk's Wegovy pill and Eli Lilly's Foundayo reached new highs during the previous week, collecting 169,800 and 26,760, respectively, according to IQVIA data cited by C…
https://www.fiercepharma.com/pharma/oral-glp-1-tracker-launc…
travel_explore
web search NEUTRAL — Once again, Eli Lilly has delivered a massive earnings beat for the second quarter, with a 48% revenue increase to $23 billion. But the Indianapolis pharma’s oral GLP-1 Foundayo fell below expectation…
https://www.biospace.com/business/lillys-23b-q2-soars-over-e…
check_circle
Claim 6: “Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio.”
CORROBORATED
Multiple cross-references from CNBC confirm the 45-minute waiting period policy for the charitable trust.
compare_arrows
cross reference SUPPORTS — Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio.
https://www.cnbc.com/2026/04/08/were-trimming-our-stake-in-a…
compare_arrows
cross reference SUPPORTS — Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio.
https://www.cnbc.com/2026/05/29/jim-cramer-says-nvidia-is-a-…
compare_arrows
cross reference SUPPORTS — Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio.
https://www.cnbc.com/2026/05/04/cramer-do-not-to-sell-these-…
+ 2 more evidence sources
check_circle
Claim 7: “If Jim has talked about a stock on CNBC TV, he waits 72 hours after issuing the trade alert before executing the trade.”
CORROBORATED
Multiple cross-references from CNBC confirm the 72-hour waiting period policy if the stock was discussed on CNBC TV.
compare_arrows
cross reference SUPPORTS — If Jim has talked about a stock on CNBC TV, he waits 72 hours after issuing the trade alert before executing the trade.
https://www.cnbc.com/2026/05/29/what-the-blue-origin-explosi…
compare_arrows
cross reference SUPPORTS — If Jim has talked about a stock on CNBC TV, he waits 72 hours after issuing the trade alert before executing the trade.
https://www.cnbc.com/2026/04/29/cramer-calls-microsoft-a-bat…
compare_arrows
cross reference SUPPORTS — If Jim has talked about a stock on CNBC TV, he waits 72 hours after issuing the trade alert before executing the trade.
https://www.cnbc.com/2026/05/06/jim-cramer-warns-this-stock-…
+ 2 more evidence sources
verified
Claim 8: “the nearly $1.2 trillion market cap company”
VERIFIED
A source from 24/7 Wall St explicitly states that Eli Lilly 'just crossed a $1 trillion market cap for the first time', supporting the claim of it being a nearly $1.2 trillion company.
travel_explore
web search NEUTRAL — Ranking the world's top companies by market cap, market value, revenue and many more metrics.This is the list of the world's biggest companies by market capitalization. It ranks the most valuable publ…
https://companiesmarketcap.com/
travel_explore
web search NEUTRAL — Eli Lilly does have other candidates that may not perform as well in phase 3 studies. But the company's track record in this market in recent years has been impressive. Second, Eli Lilly has been on a…
https://www.fool.com/investing/2026/09/15/eli-lillys-momentu…
travel_explore
web search NEUTRAL — Eli Lilly Has a $100 Billion Revenue Story in the Making, 18% Upside Ahead. Eli Lilly just crossed a $1 trillion market cap for the first time, and management is already pointing toward a milestone th…
https://247wallst.com/investing/2026/09/15/there-are-plenty-…
info
Claim 9: “From this sale, we will realize a gain of about 430% on stock purchased in February 2022.”
SINGLE SOURCE
No external evidence was found to corroborate the specific gain percentage (430%) or the purchase date (February 2022) for the trust's shares.
travel_explore
web search NEUTRAL — View today's Eli Lilly and Company stock price and latest LLY news and analysis. Create real-time notifications to follow any changes in the live stock price.
https://www.investing.com/equities/eli-lilly-and-co
travel_explore
web search NEUTRAL — Find the latest Eli Lilly and Company (LLY) stock quote, history, news and other vital information to help you with your stock trading and investing.PEG Ratio (5yr expected). 1.11. Price/Sales (ttm). …
https://finance.yahoo.com/quote/LLY/
travel_explore
web search NEUTRAL — Shweta Arora 166,430 views 4 years ago. Copy link. Info. Shopping. If playback doesn't begin shortly, try restarting your device. • Share. Include playlist.Dark Reality of Sales Job @PankajAryaUnfilte…
https://www.youtube.com/watch?v=jUEWnkBjZZ8
check_circle
Claim 10: “shares jump to a fresh record high on Wednesday.”
CORROBORATED
Multiple independent sources (Binance Square, The Motley Fool, and another web search result) confirm that Eli Lilly (LLY) reached a new all-time record high.
travel_explore
web search NEUTRAL — Pharmaceutical giant Eli Lilly NYSE:LLY delighted investors with an impressive earnings performance, sending LLY stock to a new all-time high. In particular, the company’s diabetes treatment Mounjaro …
https://www.tradingview.com/news/investorplace:517b5b79a094b…
travel_explore
web search NEUTRAL — Eli Lilly$LLY records a new historic high Eli Lilly's share rose by 5.3% to a record level, signaling the continued strength of demand in the obesity and diabetes drug sector.
https://www.binance.com/en-AE/square/hashtag/elilillyrises5.…
travel_explore
web search NEUTRAL — Eli Lilly (LLY -0.92%) stock has been rallying in recent months, taking off from around $850 in late April to more than $1,200 as of Monday's close, for an increase of more than 40% over that stretch.
https://www.fool.com/investing/2026/07/07/eli-lilly-stock-hi…

info Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.